AuBEX Corp. (3583.T)
ValueMarkers Composite Index
92% below intrinsic value ($113)
AuBEX Corp. (3583.T) — VMCI valuation read
Headline read on 3583.T: VMCI of 65/100 versus a Consumer Cyclical sector median of 50. The 15-point above-median position is what makes AuBEX Corp. a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on 3583.T: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on 3583.T: value (3583.T trades at 25.0x earnings, 39% above the Consumer Cyclical median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the Consumer Cyclical median (10.0%)), and risk (net debt to EBITDA of 1.6x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Consumer Cyclical 12.0x baseline.
3583.T rose 2.4% over the trailing 7 days, with a +2.4% read on a 30-day basis.
AuBEX CORPORATION manufactures and sells nibs and medical equipment in Japan and internationally. The company offers nibs made from polyester fibers, nylon fibers, acrylic fibers, plastics, and engineering plastics for stationery used in writing, marking, painting, and presentation, as well as for PC peripherals and industrial equipment; and nibs for makeup and cosmetics products, including porous tips and PBT brush tips, feeders, and cosmetics tips. It also provides medical equipment and components, such as pressure infusion devices and angiography guide wires for public and private university hospitals, and other hospitals. The company was formerly known as Tokyo hat Co., Ltd. and changed its name to AuBEX CORPORATION in 1985. AuBEX CORPORATION was founded in 1892 and is headquartered in Tokyo, Japan.
Related Stocks in Consumer Cyclical
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.